NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

Use of O-neg blood remained ‘relatively high’

By Mindo - 21st Jan 2020

Use of O-negative blood has remained “relatively high” despite some work undertaken to reduce usage, the CEO of the Irish Blood Transfusion Service (IBTS) reported to its board in September.

According to Mr Andrew Kelly’s report, a meeting was held with the Academy of Clinical Science and Laboratory Medicine “to discuss how we could work together to optimise the use of O-negative. We discussed a range of issues, one of which was to carry out a survey of usage patterns across the hospitals.”

In February 2019, Mr Kelly advised the board he had written to the CEOs of 13 hospitals about the matter. “From the responses to date, the view seems to be that there is nothing they can do to reduce the usage of O-negative blood. I do not believe this is reasonable.”

The IBTS reports were obtained by the Medical Independent under Freedom of Information law.

As the ‘universal’ blood group, O-negative may be used when a patient’s blood type is not known. O-negative blood is also frequently used for transfusions required for patients with sickle cell disease (who are typically of African parentage), due to the low proportion of donors who share the blood groups of these patients.

An IBTS spokesperson said the incidence of O-negative in the population is 8 per cent and the average weekly issue is 14 per cent.

“We are working with the HSE and hospitals to ensure that all groups are used optimally.”

They added that the IBTS is collaborating with Sickle Cell and Thalassemia Ireland to launch a campaign to attract more donations from the African and Asian communities, which is due to be launched by the end of March.

Leave a Reply

Latest
Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read